Premium
Study links individual antidepressants used early in pregnancy to birth defects
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30651
Subject(s) - venlafaxine , confounding , medicine , pregnancy , psychiatry , obstetrics , anxiety , antidepressant , genetics , pathology , biology
An analysis of data from the National Birth Defects Prevention Study has uncovered some associations between maternal use of antidepressants and heightened risk of birth defects, with venlafaxine linked to the highest prevalence of birth defects. The study did not fully account for potential confounding by underlying condition, however, because the data set did not include information about mothers' psychiatric diagnoses. Results were published online Aug. 5 in JAMA Psychiatry .